Literature DB >> 11753406

Regulatory functions of ubiquitination in the immune system.

Yinon Ben-Neriah1.   

Abstract

Protein modification via covalent attachment of ubiquitin has emerged as one of the most common regulatory processes in all eukaryotes; it is possibly second only to phosphorylation. In fact, ubiquitination and phosphorylation have much in common: both occur rapidly--often in response to an extracellular signal--and both are quickly reversed by a large set of dedicated enzymes termed deubiquitination enzymes and phosphatases, respectively. In addition, these two protein-modification events often cooperate in mobilizing a particular cellular pathway. Traditionally, ubiquitination has been associated with proteolytic events, mostly in conjunction with the 26S proteosome. Recently, however, ubiquitination has been implicated in other regulatory mechanisms. Some involve proteosome-independent protein degradation, whereas others are entirely proteolysis-independent, ranging from protein kinase activation to translation control. Therefore, it is not surprising that the ever-evolving immune system is an excellent mirror for the multiple roles played by ubiquitination within an organism.

Mesh:

Substances:

Year:  2002        PMID: 11753406     DOI: 10.1038/ni0102-20

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  107 in total

Review 1.  NF-kappaB/Rel transcriptional pathway: implications in pancreatic cancer.

Authors:  Hana Algül; Guido Adler; Roland M Schmid
Journal:  Int J Gastrointest Cancer       Date:  2002

2.  Loss of the anaphase-promoting complex in quiescent cells causes unscheduled hepatocyte proliferation.

Authors:  Karin G Wirth; Romeo Ricci; Juan F Giménez-Abián; Shahryar Taghybeeglu; Nobuaki R Kudo; Wolfram Jochum; Mireille Vasseur-Cognet; Kim Nasmyth
Journal:  Genes Dev       Date:  2004-01-01       Impact factor: 11.361

3.  The comparative proteomics of ubiquitination in mouse.

Authors:  Colin A M Semple
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

Review 4.  Bacterial inhibition of eukaryotic pro-inflammatory pathways.

Authors:  Andrew S Neish
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

5.  Of mice and men.

Authors:  Yinon Ben-Neriah; M Lienhard Schmitz
Journal:  EMBO Rep       Date:  2004-06-25       Impact factor: 8.807

6.  Crystal structure of human otubain 2.

Authors:  Max H Nanao; Sergey O Tcherniuk; Jadwiga Chroboczek; Otto Dideberg; Andréa Dessen; Maxim Y Balakirev
Journal:  EMBO Rep       Date:  2004-07-16       Impact factor: 8.807

Review 7.  Nuclear factor (NF)-kappaB proteins: therapeutic targets.

Authors:  I M Verma
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 8.  Oncogenic activation of NF-kappaB.

Authors:  Louis M Staudt
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

9.  Tyrosine residues direct the ubiquitination and degradation of the NY-1 hantavirus G1 cytoplasmic tail.

Authors:  Erika Geimonen; Imelyn Fernandez; Irina N Gavrilovskaya; Erich R Mackow
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling.

Authors:  Erika Scharschmidt; Elmar Wegener; Vigo Heissmeyer; Anjana Rao; Daniel Krappmann
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.